Prostate Cancer Treatment

Prostate cancer is a common urinary system malignancy that mainly occurs in men over the age of 50, with incidence increasing with age. The disease develops slowly, and early treatment can significantly improve prognosis. If the best treatment window is missed, the tumor may invade bones or distant organs, greatly increasing treatment difficulty. Current treatment strategies are increasingly diversified and individualized.

Emerging Treatment Methods

Immune Reconstruction Cell Therapy

Immune reconstruction cell therapy enhances the immune system’s ability to recognize and eliminate tumor cells, suitable for patients with locally advanced or high-risk recurrent prostate cancer. This therapy rebuilds immune recognition mechanisms to precisely eliminate cancer cells, effectively controlling disease progression with relatively few side effects, delaying recurrence, and improving prognosis.

① Collect the patient’s own immune cells, expand and activate them in vitro, then reinfuse them to enhance anti-tumor activity;

② Can be combined with radiotherapy, surgery, and other treatments to enhance overall efficacy;

③ Particularly suitable for patients intolerant to traditional chemotherapy, improving treatment tolerance and quality of life;

④ Clinical practice has shown good control rates in some recurrent or refractory cases.

During actual treatment, cancer patients undergoing surgery, radiotherapy, and chemotherapy often face immune dysfunction, increased risk of infection, and slow recovery. To better support patients, improve tolerance, and enhance survival quality, it is necessary to scientifically design phased immune reconstruction plans tailored to different treatment cycles.

● Short-term plan: Rapidly enhance immunity through immune cell reinfusion, boosting the effectiveness of anti-tumor treatment.

● Mid-term plan: Reduce side effects of traditional treatments, promote physical recovery, and complete standardized treatment courses.

● Long-term plan: Improve overall immunity through immune cell reconstruction, gut immune reconstruction, elemental immune reconstruction, and immune nutrition reconstruction, thereby enhancing quality of life and prolonging survival.

Conventional Treatment Methods

1. Radical Prostatectomy

Surgery is a standard treatment for localized prostate cancer, usually involving radical prostatectomy to remove the prostate and some surrounding tissues. This is suitable for patients in good physical condition with localized tumors. Postoperative pathology results may determine whether to combine other treatments such as radiotherapy or hormone therapy.

2. Radiotherapy (including minimally invasive intensity-modulated radiotherapy)

Radiotherapy is a non-surgical option for local or early patients. Modern Intensity-Modulated Radiotherapy (IMRT) is a minimally invasive method that precisely targets lesions based on shape, reducing damage to surrounding tissues and improving safety and efficiency. It is especially suitable for patients who cannot undergo surgery or have postoperative recurrence risk.

3. Hormone Therapy (Androgen Deprivation Therapy)

Prostate cancer cell growth depends on androgens. Hormone therapy suppresses testosterone synthesis or blocks its action to slow disease progression. It is commonly used in advanced or metastatic cases and can be combined with radiotherapy or immunotherapy. While not curative, it effectively controls symptoms and tumor burden.

4. Cryoablation and High-Intensity Focused Ultrasound (HIFU)

For elderly patients unsuitable for surgery or radiotherapy, cryoablation and HIFU are newer minimally invasive treatment options. Cryotherapy destroys cancer cells by local freezing, while HIFU uses high-intensity sound waves to precisely heat and ablate tumor tissue. These methods cause less trauma, enable faster recovery, and have fewer complications.

5. Chemotherapy and Targeted Therapy

Chemotherapy is used for castration-resistant or advanced prostate cancer, with common drugs including docetaxel and cabazitaxel. Recently, some targeted drugs, such as PARP inhibitors, have been applied to patients with specific gene mutations. These treatments help extend survival and alleviate bone metastasis symptoms.

Conclusion

Prostate cancer treatment should be tailored based on disease stage, patient constitution, and life expectancy. Experts at United Life International Medical Center emphasize that combining multiple treatment methods—especially the integration of immune reconstruction cell therapy—will help improve efficacy, reduce recurrence risk, and is a key future direction of treatment.